NCT07789093 Coaching in Palliative Surgical Oncology
| NCT ID | NCT07789093 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Singapore General Hospital |
| Condition | Palliative Care |
| Study Type | INTERVENTIONAL |
| Enrollment | 220 participants |
| Start Date | 2026-03-24 |
| Primary Completion | 2028-03-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 220 participants in total. It began in 2026-03-24 with a primary completion date of 2028-03-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the effectiveness of a serious illness coaching intervention (CONCORD) in improving quality of serious illness conversation (SIC), treatment decision-making, goal-concordant care delivery and quality of life in patients with advanced cancer considered for palliative interventions. CONCORD will be delivered by lay healthcare providers. We compare outcomes between participants receiving CONCORD vs usual care.
Eligibility Criteria
Inclusion Criteria: (i) Patient: 1. Aged 21 or above; 2. Diagnosis of advanced cancer, i.e. stage 3 or 4 solid organ 3. Consulted for palliative surgery or other interventions, i.e. procedures aimed at relieving symptoms and improving quality of life 4. Able to speak English or Mandarin; (ii) Caregiver 1. Aged 21 or above; 2. Self-endorsed or identified by the enrolled patient as an unpaid spouse/partner, relative or friend who knows them well and who provides regular care, who does not have to live in the same dwelling 3. Able to speak English or Mandarin. Exclusion Criteria: (i). Patient 1. Patient refusal, 2. Active mental illness or severe dementia, or being certified unfit to make medical decision by a specialist physician, 3. Pregnant Women (ii). Caregiver 1. Self-reported severe mental illness, dementia, active suicidal ideation, uncorrected hearing loss; 2. Unable to complete caregiver-reported outcomes.
Contact & Investigator
Jolene Si Min Wong, MBBS, MMed (Surgery), MPH
PRINCIPAL INVESTIGATOR
Singapore General Hospital
Frequently Asked Questions
Who can join the NCT07789093 clinical trial?
This trial is open to participants of all sexes, aged 21 Years or older, up to 99 Years, studying Palliative Care. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07789093 currently recruiting?
Yes, NCT07789093 is actively recruiting participants. Contact the research team at huang.xindi@nccs.com.sg for enrollment information.
Where is the NCT07789093 trial being conducted?
This trial is being conducted at Singapore, Singapore.
Who is sponsoring the NCT07789093 clinical trial?
NCT07789093 is sponsored by Singapore General Hospital. The principal investigator is Jolene Si Min Wong, MBBS, MMed (Surgery), MPH at Singapore General Hospital. The trial plans to enroll 220 participants.